Clinical Trials Sponsored by Integrative Phenomics

Total 1226 results

Integrative Phenomics
RNPC (Rééducation Nutritionnelle et Psycho-Comportementale) Network

Completed

Study of the Intestinal Microbiota During a Real Life Dietary Intervention in Subjects With Overweight or Obesity (GUTINSIDE)

Overweight and Obesity

France
Phenomix

Completed

Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Phenomix

Terminated

Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Argentina, Canada, Mexico, India
Phenomix

Unknown

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States, Argentina, Canada, India, Mexico
Verge Genomics

Recruiting

A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Canada, Netherlands
Helio Genomics

Recruiting

Multi-analyte Blood Test Clinical Trial (LIVER-1)

Liver Cirrhosis | HCC | Hepatocellular Carcinoma | Liver Cancer

United States
Pathway Genomics

Completed

Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy

Colon Cancer | Colon Adenomas | Colon Polyps

United States
Verge Genomics

Recruiting

A Study of VRG50635 in Healthy Volunteers

Healthy Volunteers

United States
Helio Genomics

Active, not recruiting

Clinical Trial Multi-analyte Blood Test (CLiMB)

Liver Cirrhosis

United States
Pathway Genomics

Terminated

ctDNA in Patients With Thyroid Nodules

Thyroid Cancer | Thyroiditis | Thyroid Adenoma | Thyroid Nodules

United States
Helio Genomics

Recruiting

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer (ELITE)

Liver Cirrhosis | Diabetes | Cancer | Hepatitis B | Hepatitis C | COPD | Chronic Hepatitis

United States
Cadex Genomics

Completed

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Metastatic Colorectal Cancer | Metastatic Breast Cancer | Metastatic Non-Small Cell Lung Carcinoma

United States, Canada
Pathway Genomics

Completed

Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease (H1000)

Neoplasms | Mutation

United States
Pathway Genomics

Terminated

Circulating Tumor DNA in Patients at High Risk for Lung Cancer

Lung Neoplasms | Lung Cancer | Adenocarcinoma of the Lung | Cancer of the Lung | Small Cell Carcinoma of the Lung | Non Small Cell Carcinoma of the Lung

United States
Integrative Psychiatry Institute

Not yet recruiting

Ketamine Therapy Experiential Education Study (KTEES1)

Psychedelic Experiences | Therapeutic Alliance | Psychology, Perceptual
Oryzon Genomics S.A.

Recruiting

Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+) (FRIDA)

Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory

United States
Singlera Genomics Inc.

Completed

Clinical Validation of ColonAiQ (a Blood-based Assay Targeting ctDNA Methylation) for Colorectal Cancer Detection

Colorectal Cancer

China
Oryzon Genomics S.A.

Completed

Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Borderline Personality Disorder

Spain, Serbia, United States, Germany, Bulgaria
American Genomics, LLC

Completed

A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution

Anesthesia, Local

United States
Quantum Genomics SA

Completed

Firibastat in Treatment-resistant Hypertension (FRESH)

Hypertension

United States, Czechia, France, Germany, Poland, Spain
Quantum Genomics SA

Completed

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension (2QG1)

Essential Hypertension

France
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

Diabetes Mellitus, Type II

United States, Belarus, India, Romania, Germany, Lithuania
Transplant Genomics, Inc.

Not yet recruiting

CLinical Utility of the omnigrAf® biomarkeR Panel In The Care of kidneY Transplant Recipients (CLARITY)

Kidney Transplant Rejection
Transplant Genomics, Inc.

Not yet recruiting

TRU-IMMUNO: Optimizing Liver Immunosuppression

Liver Transplant Rejection
Cofactor Genomics, Inc.

Recruiting

Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer (PREDAPT-HNSCC2)

Head and Neck Squamous Cell Carcinoma

United States
Bluestar Genomics Inc.

Recruiting

New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) (NODMED)

Pancreatic Cancer

United States
Transplant Genomics, Inc.

Recruiting

TruGraf® Long-term Clinical Outcomes Study

Kidney Transplant Rejection

United States
Quantum Genomics SA

Completed

Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction (QUORUM)

Myocardial Infarction

Poland, Germany, France, Hungary, Slovakia, Spain, United Kingdom
Clinical Genomics Pathology

Completed

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL (PASCAL)

Colorectal Cancer

United States
Quantum Genomics SA

Terminated

QUantum Genomics Incremental Dosing in Heart Failure - QUID-HF (QUID-HF)

Heart Failure

France, Germany, Netherlands, United Kingdom, Hungary, Norway, Czechia, Poland
Everist Genomics, Inc

Completed

Vascular Reactivity Assessment by the AngioDefender Device -- A Precision Study

Cardiovascular Diseases

Canada
Everist Genomics, Inc

Completed

AngioDefender Versus Brachial Artery Ultrasound Imaging

Cardiovascular Diseases

United States, Canada
Everist Genomics, Inc

Completed

Brachial Artery Ultrasound Imaging: A Repeatability Study

Cardiovascular Diseases

United States
Quantum Genomics SA

Completed

Study of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects

Essential Hypertension

France
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

Diabetes Mellitus, Type II

United States, Belarus, Colombia, Hungary, India, Lithuania, Peru, Romania
Phenomix
Forest Laboratories

Terminated

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Type 2 Diabetes Mellitus | Renal Impairment

United States, Russian Federation, Ukraine
American Genomics, LLC

Completed

A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population

Anesthesia, Local

United States
Convergent Genomics, Inc.

Completed

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX ) (CGI-EPM-IX)

SARS-CoV-2

United States
American Genomics, LLC

Completed

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Anesthesia, Local

United States
Shanghai Genomics, Inc.

Completed

A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis (HBV)

Hepatitis B, Chronic

China
American Genomics, LLC

Completed

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Anesthesia, Local

United States
American Genomics, LLC

Completed

An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920

Healthy

United States
Clinical Genomics Pathology

Completed

Colvera for Detection of Disease Recurrence (NOVA)

Colorectal Adenocarcinoma

United States
Quantum Genomics SA

Completed

Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins (NEW-HOPE)

Hypertension

United States
Quantum Genomics SA

Completed

Phase I Study in Healthy Male Subjects Comparing QGC001 to Placebo

Essential Hypertension

France
Sirius Genomics Inc.

Unknown

Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis

Septic Shock | Severe Sepsis

United States, Canada, France, United Kingdom
Forest Laboratories
Phenomix

Terminated

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone (REDWOOD403)

Diabetes Mellitus, Type 2

United States
Phenomix
Forest Laboratories

Terminated

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Type 2 Diabetes

United States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
Phenomix
Forest Laboratories

Terminated

Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Type 2 Diabetes Mellitus

United States, Argentina, Chile, Czech Republic, India, Peru, Poland
Phenomix
Forest Laboratories

Terminated

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Type 2 Diabetes Mellitus

United States, Argentina, India, Peru, Poland, Czech Republic

Clinical Trials Sponsored by Integrative Phenomics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations